-
-87%
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 (Developments in Cardiovascular Medicine)
0Original price was: $61.00.$8.00Current price is: $8.00.Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 (Developments in Cardiovascular Medicine), Leighton C. Whitaker, 9780792302940
